LIAONING CHENG DA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.3 CNY | +4.67% |
|
+1.78% | -12.56% |
| Sales 2021 | 18.37B 2.54B 211B | Sales 2022 | 14.56B 2.01B 168B | Capitalization | 19.19B 2.65B 221B |
|---|---|---|---|---|---|
| Net income 2021 | 2.16B 298M 24.84B | Net income 2022 | 1.22B 169M 14.08B | EV / Sales 2021 | 1.93 x |
| Net Debt 2021 | 5.57B 769M 64.1B | Net Debt 2022 | 5.36B 740M 61.67B | EV / Sales 2022 | 1.69 x |
| P/E ratio 2021 |
13.8
x | P/E ratio 2022 |
15.7
x | Employees | 3,406 |
| Yield 2021 |
1.13% | Yield 2022 |
1.19% | Free-Float | 56.44% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.67% | ||
| 1 week | +1.78% | ||
| Current month | +1.48% | ||
| 1 month | +1.58% | ||
| 3 months | -7.54% | ||
| 6 months | -14.52% | ||
| Current year | -12.56% |
1 week
9.75
10.33
1 month
9.6510.49
Current year
9.0312.06
1 year
9.0315.05
3 years
9.0326.65
5 years
9.0331.85
10 years
9.0337.59
| Managers | Title | Age | Since |
|---|---|---|---|
Hao Zhu
DFI | Director of Finance/CFO | 50 | 18/21/18 |
Yu Ge
PSD | President | 62 | 16/06/16 |
Shan Wei Zhang
BRD | Director/Board Member | 44 | 18/21/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shu Zhi Shang
CHM | Chairman | 72 | 16/06/16 |
Yu Ge
PSD | President | 62 | 16/06/16 |
Zhan Yang Yu
CHM | Chairman | 53 | 18/21/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 10.3 | +4.67% | 13,076,100 |
| 25/24/25 | 9.84 | +0.10% | 5,999,238 |
| 24/24/24 | 9.83 | -0.71% | 6,418,700 |
| 23/24/23 | 9.9 | -1.00% | 5,976,700 |
| 22/24/22 | 10 | -1.19% | 6,039,688 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Liaoning Chengda Co., Ltd. is a diversified group organized around six sectors of activity:
- retail distribution of clothes;
- consumer goods trading: chemical products, oils for food, textile products, electronic products, construction materials, health products, etc.;
- detention and operating of drugstores;
- development of vaccines;
- development of energetic projects: coalmines operating, production petrol, etc.;
- financial services.
Net sales are distributed geographically as follows: China (92.1%), Asia (4.9%), Americas (2.5%), Europe (0.2%), Africa (0.2%) and Oceania (0.1%).
Sector
Pharmaceuticals
Calendar
27/04/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -12.56% | 2.16B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600739 Stock
